LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.04
+0.14 (2.86%)
At close: Dec 20, 2024, 4:00 PM
5.18
+0.14 (2.78%)
After-hours: Dec 20, 2024, 6:33 PM EST

LifeMD Revenue

LifeMD had revenue of $53.39M in the quarter ending September 30, 2024, with 38.27% growth. This brings the company's revenue in the last twelve months to $193.06M, up 42.16% year-over-year. In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth.

Revenue (ttm)
$193.06M
Revenue Growth
+42.16%
P/S Ratio
1.04
Revenue / Employee
$914,972
Employees
211
Market Cap
218.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023152.55M33.51M28.15%
Dec 31, 2022119.03M26.16M28.16%
Dec 31, 202192.88M55.58M149.04%
Dec 31, 202037.29M24.83M199.10%
Dec 31, 201912.47M4.14M49.79%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 193.06M
SOPHiA GENETICS 64.49M
Profound Medical 8.98M
Ocugen 4.70M
Precigen 3.96M
Cardiff Oncology 688.00K
Inhibikase Therapeutics 1.00
Revenue Rankings